Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival benefit of second line therapies for recurrent hepatocellular carcinoma: repeated hepatectomy, thermoablation and second-line transplant referral in a real life national scenario.
Famularo S, Cillo U, Lauterio A, Donadon M, Vitale A, Serenari M, Cipriani F, Fazio F, Giuffrida M, Ardito F, Dominioni T, Garancini M, Lai Q, Nicolini D, Molfino S, Perri P, Pinotti E, Conci S, Ferrari C, Zanello M, Patauner S, Zimmitti G, Germani P, Chiarelli M, Romano M, De Angelis M, La Barba G, Troci A, Ferraro V, Izzo F, Antonucci A, Belli A, Memeo R, Crespi M, Ercolani G, Boccia L, Zanus G, Tarchi P, Hilal MA, Frena A, Jovine E, Griseri G, Ruzzenente A, Zago M, Grazi G, Baiocchi GL, Vivarelli M, Rossi M, Romano F, Maestri M, Giuliante F, Valle RD, Ferrero A, Aldrighetti L, De Carlis L, Cescon M, Torzilli G; HE.RC.O.LE.S. Group Contributors. Famularo S, et al. Among authors: molfino s. HPB (Oxford). 2023 Oct;25(10):1223-1234. doi: 10.1016/j.hpb.2023.06.004. Epub 2023 Jun 12. HPB (Oxford). 2023. PMID: 37357112
Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.
Bissolati M, Desio M, Rosa F, Rausei S, Marrelli D, Baiocchi GL, De Manzoni G, Chiari D, Guarneri G, Pacelli F, De Franco L, Molfino S, Cipollari C, Orsenigo E. Bissolati M, et al. Among authors: molfino s. Gastric Cancer. 2017 Jan;20(1):70-82. doi: 10.1007/s10120-015-0589-6. Epub 2016 Jan 5. Gastric Cancer. 2017. PMID: 26732876
Effect of neoadjuvant chemotherapy on HER-2 expression in surgically treated gastric and oesophagogastric junction carcinoma: a multicentre Italian study.
Chiari D, Orsenigo E, Guarneri G, Baiocchi GL, Mazza E, Albarello L, Bissolati M, Molfino S, Staudacher C; Gruppo Italiano Ricerca Cancro Gastrico (GIRCG). Chiari D, et al. Among authors: molfino s. Updates Surg. 2017 Mar;69(1):35-43. doi: 10.1007/s13304-017-0423-2. Epub 2017 Mar 8. Updates Surg. 2017. PMID: 28276033
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.
Baiocchi GL, Molfino S, Baronchelli C, Giacopuzzi S, Marrelli D, Morgagni P, Bencivenga M, Saragoni L, Vindigni C, Portolani N, Botticini M, De Manzoni G. Baiocchi GL, et al. Among authors: molfino s. World J Gastroenterol. 2017 Dec 7;23(45):8000-8007. doi: 10.3748/wjg.v23.i45.8000. World J Gastroenterol. 2017. PMID: 29259375 Free PMC article.
72 results